Ionis Board Shakeup And Valuation Gap Draw Investor Attention [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
Ionis Pharmaceuticals announced significant Board changes as two long-serving directors, including its lead independent director and a former chief operating officer/CFO, retire. Industry veteran Peter Reikes is rejoining the Ionis Board, bringing additional regulatory and sector experience to the company. These Board transitions mark a key shift in governance for Ionis Pharmaceuticals, ticker NasdaqGS:IONS. For investors watching NasdaqGS:IONS, these governance moves arrive with the stock trading at $70.99. Over the past year, the share price return is 115.7%, with a 109.1% return over three years and 65.3% over five years. Recent shorter term moves include a 14.6% decline over 30 days and a 10.9% decline year to date. Board changes of this scale can matter for how a company sets priorities, manages risk and responds to regulatory and competitive pressures. As Ionis absorbs the departure of experienced directors and the return of Peter Reikes, investors may focus on how the
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority ReviewBusiness Wire
- National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day [Yahoo! Finance]Yahoo! Finance
- Why Ionis Pharmaceuticals' (IONS) 2026 Catalyst Pipeline Supported Leerink's Higher Target [Yahoo! Finance]Yahoo! Finance
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Ionis announces changes to Board of DirectorsBusiness Wire
IONS
Earnings
- 2/25/26 - Miss
IONS
Sec Filings
- 3/24/26 - Form 144/A
- 3/23/26 - Form 4
- 3/19/26 - Form 144
- IONS's page on the SEC website